Select Page

The FDA has announced a voluntary recall for several drugs containing valsartan due to an impurity found in the products.  The impurity, N-nitrosodimethylamine (NDMA), is a likely carcinogen.  The FDA is continuing to investigate the matter, but in the meantime, it’s critical for patients and health care professionals to follow the recall instructions provided by the manufacturers of the drugs.

Patients should check their prescription bottles to determine if their specific drug is included in the recall.  Companies that have recalled products include Camber Pharmaceuticals, Solco HealthcareTeva Pharmaceuticals Industries, and Major Pharmaceuticals.

Note that due to the seriousness of the conditions treated by valsartan such as high blood pressure, the FDA is recommending that patients continue to take the medication until a replacement product has been procured.